FDA OKs Linzess for Kids with IBS-C - First Pediatric Treatment
In a groundbreaking medical advancement, the FDA has approved Linzess (linaclotide) for children aged 7+ with IBS-C, offering the first dedicated treatment for pediatric constipation and abdominal pain.